Reply to the letter “Body mass index and clinical outcomes in trastuzumab-treated metastatic breast cancer patients

An alternative explanation for the lack of association”

Elena Poletto, Samuel Martel, Matteo Lambertini, Fabio Puglisi

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)151-152
Number of pages2
JournalBreast
Volume39
DOIs
Publication statusPublished - Jun 1 2018

ASJC Scopus subject areas

  • Surgery

Cite this

Reply to the letter “Body mass index and clinical outcomes in trastuzumab-treated metastatic breast cancer patients : An alternative explanation for the lack of association”. / Poletto, Elena; Martel, Samuel; Lambertini, Matteo; Puglisi, Fabio.

In: Breast, Vol. 39, 01.06.2018, p. 151-152.

Research output: Contribution to journalLetter

@article{b2077153509040049ca0432e29e64c6b,
title = "Reply to the letter “Body mass index and clinical outcomes in trastuzumab-treated metastatic breast cancer patients: An alternative explanation for the lack of association”",
author = "Elena Poletto and Samuel Martel and Matteo Lambertini and Fabio Puglisi",
year = "2018",
month = "6",
day = "1",
doi = "10.1016/j.breast.2018.03.003",
language = "English",
volume = "39",
pages = "151--152",
journal = "Breast",
issn = "0960-9776",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Reply to the letter “Body mass index and clinical outcomes in trastuzumab-treated metastatic breast cancer patients

T2 - An alternative explanation for the lack of association”

AU - Poletto, Elena

AU - Martel, Samuel

AU - Lambertini, Matteo

AU - Puglisi, Fabio

PY - 2018/6/1

Y1 - 2018/6/1

UR - http://www.scopus.com/inward/record.url?scp=85046482536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046482536&partnerID=8YFLogxK

U2 - 10.1016/j.breast.2018.03.003

DO - 10.1016/j.breast.2018.03.003

M3 - Letter

VL - 39

SP - 151

EP - 152

JO - Breast

JF - Breast

SN - 0960-9776

ER -